Glenmark reduced Favipiravir price to Rs 75 per tab from Rs 103 per tab earlier

Quick Update:

Glenmark sells the drug, used in the treatment of COVID-19, under the brand name FabiFlu. The oral antiviral favipiravir has been approved under emergency use authorization for the treatment of mild to moderate COVID-19 patients.

Glenmark Pharmaceuticals has said that it has reduced the price of its favipiravir drug to Rs 75 per tablet from Rs 103 per tablet it was charging earlier.


Recent Posts

See All

Admin Login by RSP

Admin Login by Center Team

Dear Visitors !

Articles written by authors are their views and their presentation of ideas and knowledge. CHEARS does not claim right on write-up and authors are the real owner and are responsible for their write-up or views. Posts from CHEARS News Room are interpretations or presentation of news from various news resources. 

Posts from executive committee members are posts from CHEARS Office.  

© Copyright CHEARS

© Center for Health Education, Awareness Resources and Services

Subscribe to Our Newsletter